Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Motil Cytoskeleton ; 64(1): 19-48, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17029291

RESUMO

Rat Myo16a and Myo16b comprise the founding members of class XVI myosin and are characterized by an N-terminal ankyrin repeat domain thought to mediate an association with protein phosphatase 1 catalytic subunits 1alpha and 1gamma. Myo16b is the principal isoform and reveals predominant expression in developing neural tissue. Here, we use COS-7 cells as a model system to develop an understanding of Myo16b function. We find that Myo16b displays predominant localization in the nucleus of cells transitioning through interphase, but is not associated with processes of mitosis. Using a panel of EGFP-Myo16b-expression plasmids in transient transfection studies, we identified the COOH-terminal residues 1616-1912 as necessary and solely sufficient to target Myo16b to the nucleus. We show that the Myo16b-tail region directs localization to a nuclear compartment containing profilin and polymerized actin, which appears to form a three-dimensional meshwork through the depth of the nucleus. Further, we demonstrate that this compartment localizes within euchromatic regions of the genome and contains proliferating cell nuclear antigen (PCNA) and cyclin A, both markers of S-phase of the cell cycle. Cells transiently expressing Myo16b or Myo16b-tail region show limited incorporation of BrdU, delayed progression through S-phase of the cell cycle, and curtailed cellular proliferation.


Assuntos
Núcleo Celular/metabolismo , Miosinas/metabolismo , Fase S , Actinas/metabolismo , Sequência de Aminoácidos , Animais , Células COS , Proliferação de Células , Chlorocebus aethiops , Ciclina A/metabolismo , Citoplasma/metabolismo , Citometria de Fluxo , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Immunoblotting , Mitose , Dados de Sequência Molecular , Miosinas/genética , Neurônios/citologia , Neurônios/metabolismo , Matriz Nuclear/metabolismo , Profilinas/metabolismo , Antígeno Nuclear de Célula em Proliferação/metabolismo , Ratos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Homologia de Sequência de Aminoácidos , Transfecção
2.
Glia ; 37(3): 275-90, 2002 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-11857686

RESUMO

Caveolin-1 is the principal structural and functional component of caveolae, a plasmalemmal compartment that has been proposed to sequester lipid and protein components that participate in transmembrane signal transduction processes. Multiple studies reveal a reduction in the expression level of caveolin-1 mRNA and protein in many carcinomas as well as transformed cells. The human caveolin-1 gene is localized to a suspected tumor suppressor locus (7q31.1). Collectively, these data have been taken to imply that caveolin-1 may function in a tumor suppressor capacity. To determine if a reduction in the expression level of caveolin-1 mRNA and protein accompanied the transformation of astrocytes, we undertook studies of two transformed rat astroglial cell lines, C6 and DI TNC(1), as well as several cell lines derived from human glioblastoma tumors: T98G, U87MG, U118MG, U138MG, and U373MG. Ultrastructural, immunolocalization, immunoblot, and Northern blot analyses demonstrated that caveolin-1 message and protein were expressed in all rat and human glioma cells. The localization pattern, buoyant density, and detergent-insolubility property of caveolin-1 protein were indistinguishable from that determined for nontransformed type 1 astrocytes in culture. Nucleotide sequence analyses of caveolin-1 cDNAs indicate that mutations are not present in the caveolin-1 sequence in any of the glioma cell types. Taken together with previous analyses, these data indicate that, at least for astrocytes, the process of transformation in and of itself is not solely sufficient to reduce the level of caveolin-1 expression, and that caveolin-1 expression in and of itself is not solely sufficient to prevent the acquisition of a transformed phenotype.


Assuntos
Astrócitos/metabolismo , Astrocitoma/metabolismo , Neoplasias Encefálicas/metabolismo , Cavéolas/metabolismo , Caveolinas/metabolismo , Transformação Celular Neoplásica/metabolismo , Regulação Neoplásica da Expressão Gênica/fisiologia , Animais , Animais Recém-Nascidos , Astrócitos/patologia , Astrócitos/ultraestrutura , Astrocitoma/genética , Astrocitoma/patologia , Sequência de Bases/genética , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patologia , Cavéolas/patologia , Cavéolas/ultraestrutura , Caveolina 1 , Caveolinas/genética , Linhagem Celular Transformada/metabolismo , Linhagem Celular Transformada/patologia , Linhagem Celular Transformada/ultraestrutura , Transformação Celular Neoplásica/genética , Feminino , Humanos , Imuno-Histoquímica , Camundongos , Camundongos Nus , Microscopia Eletrônica , Mutação/genética , Fenótipo , Gravidez , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Homologia de Sequência de Aminoácidos , Transplante de Tecidos , Células Tumorais Cultivadas/metabolismo , Células Tumorais Cultivadas/patologia , Células Tumorais Cultivadas/ultraestrutura , Proteína Supressora de Tumor p53/deficiência , Proteína Supressora de Tumor p53/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...